查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1625315

2030年防伪药品包装市场预测：按产品类型、印刷技术、包装类型、应用和地区进行的全球分析

Anti-Counterfeit Pharmaceutical Packaging Market Forecasts to 2030 - Global Analysis By Product, Printing Technology, Packaging Type, Application and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2024年全球防伪药品包装市场规模为1,858.2亿美元，预计到2030年将达到4,231.4亿美元，预测期内复合年增长率为14.7%。

防伪药品包装对于维护病人安全和保护药品的完整性至关重要。包装采用最尖端科技来验证产品并防止假冒，包括全像图、RFID 标籤、二维码和防篡改贴纸。这使得药品可以在整个供应链中轻鬆跟踪和追踪，帮助製造商满足严格的法规并赢得客户。

据世界卫生组织(WHO)称，2000年查出的假药中有32%不含有活性成分，20%活性成分含量错误，21%成分错误，6%成分正确。 %杂质含量高，1%是仿冒品。

仿冒品不断增加

製药公司、政府和医疗保健提供者都对不断增长的假药世界深感担忧。除了危及病人安全外，假药还可能是伪造、掺假或核准的，并可能损害製药公司的声誉。根据世界卫生组织等报告，假药占世界药品贸易量的比例高达10%。此外，这一比例在低收入和中等收入国家甚至更高。这些日益严重的威胁迫使製药公司实施防伪包装解决方案作为预防措施，以确保其产品的安全性和真实性。

执行复杂度

将防伪包装解决方案纳入目前的供应链程序可能既困难又耗时。製药公司经常需要与製造商、经销商和供应商协调，以确保新技术与现有包装系统的顺利相容。例如，追踪和序列化系统需要广泛的供应链协调才能正常运作。此外，这种复杂性阻碍了大规模实施，因为它会造成延迟、业务效率低下和潜在的错误，特别是对于拥有不同供应链的公司。

人们对追踪和序列化技术越来越感兴趣

序列化和追踪解决方案的采用很大程度上是由于对端到端供应链可视性的日益关注所推动的。世界各地的政府和监管机构正在推动序列化，以确保供应链的透明度，特别是对于特殊药品和高价值药品。为序列化提供尖端硬体、软体和整合平台的公司将从中受益匪浅。此外，区块链技术正在成为追踪系统的游戏规则改变者，允许不可变的即时药品记录。

数位解决方案中的网路安全风险

网路攻击的脆弱性来自于对区块链、物联网和云端基础的追踪系统等数位技术的日益依赖。骇客可以针对身分验证平台、区块链网路和序列化资料库来篡改产品资料、破坏供应链并创建虚假数位凭证。这些网路安全风险破坏了对数位防伪解决方案的信任，使製药公司和消费者都面临风险。此外，需要采取强有力的网路安全措施来应对这些威胁，从而增加了实施防伪技术的整体成本和复杂性。

COVID-19 的影响：

COVID-19 大流行对防伪药品包装市场产生了重大影响，因为在疫苗和治疗药物等假药氾滥的情况下，增加了对安全包装选择的需求。全球健康危机带来了更严格的监管和快速采用序列化、区块链和防篡改包装等技术来确保产品的真实性，这暴露了药品供应链的弱点。然而，在一些地区，与疫情相关的供应链中断、劳动力短缺和预算限制暂时阻碍了先进包装系统的实施。

追踪科技产业预计将在预测期内成为最大的产业

防伪药品包装市场预计将由 Track &Trace Technologies 主导。能够在整个药品供应链中提供即时可见性和身份验证，帮助製造商满足严格的药品安全监管要求，这就是该行业占据主导地位的原因。条码、RFID、QR 码和序列化等追踪技术可以追踪产品从製造到交付的整个过程，确保透明度并减少假药进入市场的可能性。此外，数位解决方案、区块链和云端基础的技术的使用越来越多，使得追踪系统更加高效和扩充性。

预计 RFID 产业在预测期内复合年增长率最高

在防伪药品包装市场中，RFID（无线射频辨识）领域预计将以最高的复合年增长率成长。对确保药品即时追踪、可追溯性和认证的最尖端科技日益增长的需求推动了 RFID 系统的采用。与传统条码技术相比，RFID标籤无需直接可见即可顺利撷取资料，效率更高。此外，由于成本降低、标籤小型化以及与区块链和物联网解决方案整合等技术进步，RFID 的采用正在加速。

比最大的地区

北美地区预计将在防伪药品包装市场中占据最大份额，这主要是由于对打击假药的复杂包装解决方案的需求不断增加。此外，《药品品质和安全法案》(DQSA) 强制要求药品进行序列化和可追溯性，这是美国成为主要贡献者的严格法规之一。该地区的製药业十分发达，由于人们对药品安全性的日益关注，全像图、RFID和二维码等防伪技术在包装中已广泛应用。

复合年增长率最高的地区：

由于製药业的爆炸性增长、医疗保健支出的增加以及新兴国家对假药的担忧日益增加，预计亚太地区的防伪药品包装市场将呈现最高的复合年增长率。中国和印度等国家已大幅改善其医疗基础设施和法律规范，以防止药品假冒。此外，该地区不断壮大的中阶以及对安全和负担得起的药品不断增长的需求进一步推动了防伪药品包装技术的采用。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球防伪药品包装市场：依产品类型

  • 隐藏功能
  • 明显特征
  • 法医学标记
  • 窜改的证据
  • 追踪技术

第六章全球防伪药品包装市场：印刷技术

  • RFID
  • 安全油墨和涂料
  • 安全封条
  • 全息图
  • 大规模加密
  • 条码
  • 海量连载

第七章全球防伪药品包装市场：依包装类型

  • 瓶子
  • 泡壳包装
  • 注射器
  • 管瓶
  • 小袋

第八章全球防伪药品包装市场：依应用分类

  • 製药/生物学
  • 医疗用品
  • 手套
  • 剪刀
  • 注射器和针头
  • 手术胶带
  • 其他用途

第九章全球防伪药品包装市场：依地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 公司概况

  • 3M Company
  • Zebra Technologies Corporation
  • Ardagh Group SA
  • Systech International
  • OpSec Security Inc.
  • CCL Industries Inc.
  • AlpVision SA
  • DuPont
  • Impinj, Inc.
  • Nipro Corporation
  • Applied DNA Sciences Inc.
  • Stevanato Group
  • TruTag Technologies, Inc.
  • CFC International, Inc.
  • Savi Technology Inc.
Product Code: SMRC28270

According to Stratistics MRC, the Global Anti-Counterfeit Pharmaceutical Packaging Market is accounted for $185.82 billion in 2024 and is expected to reach $423.14 billion by 2030 growing at a CAGR of 14.7% during the forecast period. Anti-counterfeit pharmaceutical packaging is essential for maintaining patient safety and protecting the integrity of medications. This packaging uses cutting-edge technologies to authenticate products and stop counterfeiting, including holograms, RFID tags, QR codes, and tamper-evident seals. It makes it possible to track and trace pharmaceutical products easily throughout the supply chain, which helps manufacturers meet strict regulations and win over customers.

According to the World Health Organization (WHO), in 2000, 32% of identified counterfeit drugs contained no active ingredients, 20% had incorrect quantities of active ingredients, 21% had the wrong ingredients, 6% had correct composition with fake packaging, 9% contained high levels of impurities while 1% was copies of an original product.

Market Dynamics:

Driver:

Rising drug counterfeit incidence

Pharmaceutical companies, governments, and healthcare providers are all very concerned about the startling global increase in counterfeit medications. In addition to endangering patient safety, counterfeit medications-which include phony, inferior, or unapproved products-also damage pharmaceutical companies' reputations. Reports from agencies like the WHO indicate that counterfeit medications comprise up to 10% of the world's pharmaceutical trade. Additionally, this percentage is even higher in low- and middle-income nations. Pharmaceutical companies have been forced to implement anti-counterfeit packaging solutions as a preventative measure to guarantee the safety and authenticity of their products due to this growing threat.

Restraint:

Complexity of execution

Anti-counterfeit packaging solutions can be difficult and time-consuming to integrate into current supply chain procedures. Pharmaceutical businesses frequently need to coordinate with manufacturers, distributors, and suppliers in order to ensure smooth compatibility between new technologies and their existing packaging systems. For instance, track-and-trace and serialization systems require extensive supply chain coordination to work properly. Furthermore, large-scale adoption is hampered by this complexity since it raises the possibility of delays, operational inefficiencies, and mistakes, especially for businesses with disjointed supply chains.

Opportunity:

Growing interest in track-and-trace and serialization technologies

Adoption of serialization and track-and-trace solutions is greatly aided by the increased focus on end-to-end supply chain visibility. Serialization is being pushed by governments and regulatory bodies worldwide to guarantee transparency in the pharmaceutical supply chain, especially for specialty and expensive medications. Businesses that provide cutting-edge hardware, software, and integrated platforms for serialization stand to gain greatly from this. Moreover, Blockchain technology is becoming a game-changer for track-and-trace systems, allowing for the immutable, real-time recording of pharmaceutical products.

Threat:

Risks to cybersecurity for digital solutions

Cyber attack vulnerabilities are brought about by our growing reliance on digital technologies like blockchain, the Internet of Things, and cloud-based track-and-trace systems. In order to alter product data, interfere with supply chains, or create fake digital credentials, hackers may target authentication platforms, blockchain networks, or serialization databases. These cybersecurity risks endanger both pharmaceutical companies and consumers by undermining confidence in digital anti-counterfeit solutions. Additionally, strong cybersecurity measures are necessary to counter these threats, which raise the overall cost and complexity of putting anti-counterfeit technologies into place.

Covid-19 Impact:

The COVID-19 pandemic had a major effect on the market for anti-counterfeit pharmaceutical packaging because it increased demand for safe packaging options amid a spike in fake medications, such as vaccines and treatments. Stricter regulations and the quick adoption of technologies like serialization, blockchain, and tamper-evident packaging to guarantee product authenticity were brought about by the global health crisis, which exposed weaknesses in pharmaceutical supply chains. However, in some areas, the adoption of advanced packaging systems was momentarily hampered by pandemic-related supply chain interruptions, labor shortages, and budgetary restrictions.

The Track & Trace Technologies segment is expected to be the largest during the forecast period

The market for anti-counterfeit pharmaceutical packaging is anticipated to be dominated by the Track & Trace Technologies segment. Its ability to offer real-time visibility and authentication across the pharmaceutical supply chain, assisting manufacturers in meeting the strict regulatory requirements for drug safety, is the reason for its dominance. Track and trace technologies, including bar-coding, RFID, QR codes, and serialization, allow products to be tracked from manufacturing to delivery, guaranteeing transparency and lowering the possibility of fake medications reaching the market. Moreover, the efficiency and scalability of track & trace systems are further improved by the increasing use of digital solutions, blockchain, and cloud-based technologies.

The RFID segment is expected to have the highest CAGR during the forecast period

In the anti-counterfeit pharmaceutical packaging market, the RFID (Radio Frequency Identification) segment is anticipated to grow at the highest CAGR. RFID system adoption is being driven by the growing need for cutting-edge technologies that guarantee pharmaceutical products' real-time tracking, traceability, and authentication. Compared to conventional bar-coding techniques, RFID tags offer greater efficiency by facilitating smooth data capture without direct line of sight. Additionally, RFID adoption is being accelerated by advancements in the technology, such as cost reduction, tag miniaturization, and integration with Blockchain and IoT solutions.

Region with largest share:

The North American region is expected to hold the largest share in the anti-counterfeit pharmaceutical packaging market, mainly due to the growing need for sophisticated packaging solutions to fight counterfeit medications. Furthermore, the Drug Quality and Security Act (DQSA), which requires pharmaceutical products to be serialized and traceable, is one of the strict regulations that make the U.S. a major contributor. Due to the region's established pharmaceutical industry and growing concerns about drug security and safety, anti-counterfeit technologies like holograms, RFID, and QR codes have become widely used in packaging.

Region with highest CAGR:

Due to the pharmaceutical industry's explosive growth, rising healthcare spending, and growing concerns about fake medications in emerging economies, the Asia Pacific region is anticipated to have the highest CAGR in the anti-counterfeit pharmaceutical packaging market. Significant improvements are being made in healthcare infrastructure and regulatory frameworks in nations like China and India with the goal of preventing drug counterfeiting. Moreover, the adoption of anti-counterfeit packaging technologies is further fueled by the region's growing middle class and the rising demand for safe and reasonably priced pharmaceutical products.

Key players in the market

Some of the key players in Anti-Counterfeit Pharmaceutical Packaging market include 3M Company, Zebra Technologies Corporation, Ardagh Group S.A., Systech International, OpSec Security Inc., CCL Industries Inc., AlpVision SA, DuPont, Impinj, Inc., Nipro Corporation, Applied DNA Sciences Inc., Stevanato Group, TruTag Technologies, Inc., CFC International, Inc. and Savi Technology Inc.

Key Developments:

In August 2024, Systech Bhd has entered into a head of agreement (HOA) with MDT Innovations Sdn Bhd (MDT) and its founder, Liew Choon Lian (LCL), for the potential acquisition of either part or all of the equity interest or business undertakings of MDT and its group of companies.

In March 2024, Ardagh Glass Packaging-North America, an operating business of Ardagh Group, has partnered with Stevens Point Brewery to locally supply the brewery's glass beer bottles. The partnership connects Stevens Point Brewery with AGP-North America's Burlington, Wis., glass manufacturing facility, helping to keep the brewery's promise to source local products and incorporate sustainable practices into its operations.

In March 2024, 3M and HD Hyundai Korea Shipbuilding & Marine Engineering (KSOE) have signed a joint research project agreement to develop large liquid hydrogen storage tanks using Glass Bubbles from 3M - a high-strength, low-density hollow glass microsphere. The collaborative research will focus on developing a high-performance vacuum insulation system for liquified hydrogen storage and transportation.

Products Covered:

  • Covert Features
  • Overt Features
  • Forensic Markers
  • Tamper Evidence
  • Track & Trace Technologies

Printing Technologies Covered:

  • RFID
  • Security Inks & Coatings
  • Security Seals
  • Holograms
  • Mass Encryption
  • Barcode
  • Mass Serialization

Packaging Types Covered:

  • Bottles
  • Blister Packs
  • Syringes
  • Vials
  • Pouches

Applications Covered:

  • Pharma & Biological
  • Medical & Supplies
  • Gloves
  • Scissors
  • Syringes & Needles
  • Surgical Tapes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Anti-Counterfeit Pharmaceutical Packaging Market, By Product

  • 5.1 Introduction
  • 5.2 Covert Features
  • 5.3 Overt Features
  • 5.4 Forensic Markers
  • 5.5 Tamper Evidence
  • 5.6 Track & Trace Technologies

6 Global Anti-Counterfeit Pharmaceutical Packaging Market, By Printing Technology

  • 6.1 Introduction
  • 6.2 RFID
  • 6.3 Security Inks & Coatings
  • 6.4 Security Seals
  • 6.5 Holograms
  • 6.6 Mass Encryption
  • 6.7 Barcode
  • 6.8 Mass Serialization

7 Global Anti-Counterfeit Pharmaceutical Packaging Market, By Packaging Type

  • 7.1 Introduction
  • 7.2 Bottles
  • 7.3 Blister Packs
  • 7.4 Syringes
  • 7.5 Vials
  • 7.6 Pouches

8 Global Anti-Counterfeit Pharmaceutical Packaging Market, By Application

  • 8.1 Introduction
  • 8.2 Pharma & Biological
  • 8.3 Medical & Supplies
  • 8.4 Gloves
  • 8.5 Scissors
  • 8.6 Syringes & Needles
  • 8.7 Surgical Tapes
  • 8.8 Other End Users

9 Global Anti-Counterfeit Pharmaceutical Packaging Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 3M Company
  • 11.2 Zebra Technologies Corporation
  • 11.3 Ardagh Group S.A.
  • 11.4 Systech International
  • 11.5 OpSec Security Inc.
  • 11.6 CCL Industries Inc.
  • 11.7 AlpVision SA
  • 11.8 DuPont
  • 11.9 Impinj, Inc.
  • 11.10 Nipro Corporation
  • 11.11 Applied DNA Sciences Inc.
  • 11.12 Stevanato Group
  • 11.13 TruTag Technologies, Inc.
  • 11.14 CFC International, Inc.
  • 11.15 Savi Technology Inc.

List of Tables

  • Table 1 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Covert Features (2022-2030) ($MN)
  • Table 4 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Overt Features (2022-2030) ($MN)
  • Table 5 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Forensic Markers (2022-2030) ($MN)
  • Table 6 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Tamper Evidence (2022-2030) ($MN)
  • Table 7 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Track & Trace Technologies (2022-2030) ($MN)
  • Table 8 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Printing Technology (2022-2030) ($MN)
  • Table 9 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By RFID (2022-2030) ($MN)
  • Table 10 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Security Inks & Coatings (2022-2030) ($MN)
  • Table 11 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Security Seals (2022-2030) ($MN)
  • Table 12 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Holograms (2022-2030) ($MN)
  • Table 13 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Mass Encryption (2022-2030) ($MN)
  • Table 14 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Barcode (2022-2030) ($MN)
  • Table 15 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Mass Serialization (2022-2030) ($MN)
  • Table 16 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Packaging Type (2022-2030) ($MN)
  • Table 17 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Bottles (2022-2030) ($MN)
  • Table 18 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Blister Packs (2022-2030) ($MN)
  • Table 19 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Syringes (2022-2030) ($MN)
  • Table 20 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Vials (2022-2030) ($MN)
  • Table 21 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Pouches (2022-2030) ($MN)
  • Table 22 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Application (2022-2030) ($MN)
  • Table 23 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Pharma & Biological (2022-2030) ($MN)
  • Table 24 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Medical & Supplies (2022-2030) ($MN)
  • Table 25 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Gloves (2022-2030) ($MN)
  • Table 26 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Scissors (2022-2030) ($MN)
  • Table 27 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Syringes & Needles (2022-2030) ($MN)
  • Table 28 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Surgical Tapes (2022-2030) ($MN)
  • Table 29 Global Anti-Counterfeit Pharmaceutical Packaging Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.